On behalf of the EUFEMED Board, you are kindly invited to the EUFEMED General Assembly 2022. It will be a virtual event; you will receive the dial-in information shortly. As EUFEMED needs to register the attendees, we kindly ask you to confirm your presence by registering, if you are planning to attend (Healixia members only - login first to register). 

Join us at the end of spring for an informal get-together, where you can meet long-known and new peers over some good food and drinks. Don't miss the keynote by Thierry Geerts, Country Director at Google Belgium, on his book 'Homo Digitalis' and his view on the impact of digital revolution on healthcare! Every participant receives a copy of his book.

On the agenda:  Approval activity report and financials Healixia 2021 Approval action plan and budget Healixia 2022 Mandates Board Members: ‘discharge’, election Board 2023-2025 Program: 16h45: Registration 17h00: General Assembly

This online workshop will discuss the IB (Investigator's Brochure) structure, content and quality as important topics for all parties involved in planning, set-up, conduct and interpretation of a clinical study. Some practical highlights will be shared on challenges on writing a “good” IB for a FIH/Early Phase trial on the one hand, and on how to use it for an optimal benefit-risk assessment on the other hand. 

This two-day course is intended to provide an in depth knowledge and understanding of the main principles and concepts of the Quality part of the Common Technical Document. 

Online meeting In this webinar, the results of conducted research on the impact of Covid-19 on clinical trial execution will be discussed by Prof. Yves Geysels (Dept of Biomedical Sciences, University of Namur) and Florent Piraux.